Attached files

file filename
8-K - FORM 8-K - CENTENE CORPform8k.htm
Exhibit 99.1
 
GRAPHIC
 NEWS RELEASE
 
Contact:
Investor Relations Inquiries
Edmund E. Kroll
 
Senior Vice President, Finance & Investor Relations
 
(212) 759-0382
 
 
Media Inquiries
 
Deanne Lane
 
Vice President, Media Affairs
 
(314) 725-4477

FOR IMMEDIATE RELEASE

– CENTENE CORPORATION REPORTS 2011 FOURTH QUARTER AND FULL YEAR EARNINGS –
– FOURTH QUARTER EARNINGS OF $0.57 PER DILUTED SHARE –
– FULL YEAR EARNINGS OF $2.12 PER DILUTED SHARE –

ST. LOUIS, MISSOURI (February 7, 2012) -- Centene Corporation (NYSE: CNC) today announced its financial results for the quarter and year ended December 31, 2011.  As previously discussed, beginning with the fourth quarter of 2011, we have reclassified certain medical costs to more closely align with the NAIC definitions.  All of the information in this release has been reclassified to conform to the current presentation. For additional information, the details of the reclassification are provided in the supplemental financial data of this release.
 
2011 Highlights
 
Q4
   
Full Year
 
 Premium and Service Revenues (in millions)
$
1,458.5
   
$
5,181.0
 
 Consolidated Health Benefits Ratio
 
85.9
%
   
85.2
%
 General & Administrative expense ratio
 
11.0
%
   
11.3
%
 Diluted EPS
$
0.57
   
$
2.12
(1)
 Cash flow from operations (in millions)
$
172.0
   
$
261.7
 

(1) Includes $0.10 per share of debt extinguishment costs.
 
 
 

 
 
Fourth Quarter Highlights
 
·  
Quarter-end managed care at-risk membership of 1,816,000, an increase of 18.4% year over year.
 
·  
Premium and Service Revenues of $1.5 billion, representing 29.1% year over year growth.
 
·  
Health Benefits Ratio of 85.9%, compared to 85.0% in the prior year and 85.0% in the third quarter of 2011.
 
·  
General and Administrative expense ratio of 11.0%, compared to 11.3% in the prior year.
 
·  
Diluted earnings per share from continuing operations of $0.57, an increase of 14.0% from the prior year.
 
·  
Employees increased from 4,200 at December 31, 2010 to 5,300 at December 31, 2011, reflecting our continued business expansions.
 
 
Other Events
 
·  
In January 2012, we were selected to contract with the Washington Health Care Authority to serve Medicaid beneficiaries in the state.  Operations are expected to commence in the third quarter of 2012.
 
·  
In February 2012, Louisiana Healthcare Connections began operating under a new contract in Louisiana to provide healthcare services to Medicaid enrollees participating in the Bayou Health program.  In addition, Nurtur, our subsidiary which provides life, health and wellness programs, commenced operations to provide disease management services for state employees in Louisiana beginning in January 2012.
 
 
 

 
Centene Corporation Reports 2011 Fourth Quarter and Full Year Results February 7, 2012/Page 2
 
Michael F. Neidorff, Centene’s Chairman and Chief Executive Officer, stated, “During 2011, we were able to successfully demonstrate our ability to grow through new contract awards and expansions, while continuing to focus on our targeted margins.  I look forward to the new business commencing in 2012 and the opportunity to develop additional markets.”  
 
The following table depicts membership in Centene’s managed care organizations, by state:

   
December 31,
 
   
2011
 
2010
 
 Arizona
    23,700     22,400  
 Florida
    198,300     194,900  
 Georgia
    298,200     305,800  
 Illinois
    16,300      
 Indiana
    206,900     215,800  
 Kentucky
    180,700      
 Massachusetts
    35,700     36,200  
 Mississippi
    31,600      
 Ohio
    159,900     160,100  
 South Carolina
    82,900     90,300  
 Texas
    503,800     433,100  
 Wisconsin
    78,000     74,900  
Total at-risk membership
    1,816,000     1,533,500  
 Non-risk membership
    4,900     4,200  
Total
    1,820,900     1,537,700  

The following table depicts membership in Centene’s managed care organizations, by member category:
 
   
December 31,
 
   
2011
 
2010
 
 Medicaid
    1,336,800     1,177,100  
 CHIP & Foster Care
    213,900     210,500  
 ABD & Medicare
    218,000     104,600  
 Hybrid Programs
    40,500     36,200  
 Long-term Care
    6,800     5,100  
Total at-risk membership
    1,816,000     1,533,500  
 Non-risk membership
    4,900     4,200  
Total
    1,820,900     1,537,700  

Statement of Operations: Three Months Ended December 31, 2011

·  
For the fourth quarter of 2011, Premium and Service Revenues increased 29.1% to $1.5 billion from $1.1 billion in the fourth quarter of 2010.  The increase was primarily driven by new operations in Mississippi, Illinois and Kentucky added during 2011, Texas expansion and overall membership growth.
 
·  
Consolidated HBR of 85.9% for the fourth quarter of 2011 represents an increase of 0.9% from the comparable period in 2010 and from the third quarter of 2011.  This increase is primarily a result of the commencement of operations in Kentucky in November 2011.

·  
Consolidated G&A expense ratio for the fourth quarter of 2011 was 11.0%, compared to 11.3% in the prior year.  The decrease is a result of leveraging our costs over higher revenues, offset by additional business expansion costs.
 
·  
Earnings from operations increased to $47.4 million in the fourth quarter 2011 from $45.5 million in the fourth quarter 2010.  Net earnings from continuing operations were $30.1 million in the fourth quarter 2011, compared to $25.5 million in the fourth quarter of 2010.
 
·  
Earnings per diluted share increased to $0.57 in the fourth quarter of 2011 compared to $0.50 in the prior year.
 
Statement of Operations: Year Ended December 31, 2011

·  
For the year ended December 31, 2011, Premium and Service Revenues increased 20.9% to $5.2 billion from $4.3 billion in 2010.  The increase was driven by the commencement of operations in Mississippi, Kentucky and Illinois during 2011, Texas expansion and membership growth.
 
·  
Consolidated HBR of 85.2% for 2011 represents a decrease of 0.3% from 2010 primarily as a result of lower levels of utilization and contract enhancements, partially offset by our Kentucky health plan which began operations in November 2011.

·  
Consolidated G&A expense ratio for 2011 was 11.3%, compared to 11.2% in the prior year.  The increase is primarily due to additional business expansion costs, offset by leveraging our expenses over higher revenues.
 
·  
Earnings from operations increased to $190.3 million in 2011 from $157.1 million in 2010, or 21.2% year over year.  Net earnings from continuing operations were $111.2 million in 2011, compared to $90.9 million in 2010.
 
·  
Earnings per diluted share increased to $2.12 in 2011, including $(0.10) of debt extinguishment costs, compared to $1.80 in the prior year.
 
 
 

 
Centene Corporation Reports 2011 Fourth Quarter and Full Year Results February 7, 2012/Page 3
 
Balance Sheet and Cash Flow

At December 31, 2011, the Company had cash, investments and restricted deposits of $1,237.1 million, including $38.2 million held by its unregulated entities.  Medical claims liabilities totaled $608.0 million, representing 45.3 days in claims payable.  Total debt was $351.6 million and debt to capitalization was 22.6% at December 31, 2011 excluding the $77.8 million non-recourse mortgage note.  Cash flows from operations for the year ended December 31, 2011 were $261.7 million, or 2.4 times net earnings.

A reconciliation of the Company’s change in days in claims payable from the immediately preceding quarter-end is presented below:

 Days in claims payable, September 30, 2011
  43.6 *   
   Impact of new business
  1.8  
   Ohio pharmacy carve in
  (0.8)  
   Timing of claim payments
  0.7  
 Days in claims payable, December 31, 2011
  45.3  

* Days in claims payable for September 30, 2011 have been reduced by 1.0 day to reflect the medical cost reclassification.

Outlook

The table below depicts the Company’s annual guidance for 2012:

   
Full Year 2012
 
   
Low
   
High
 
 Premium and Service Revenues (in millions)
  $ 7,200     $ 7,600  
 Diluted EPS
  $ 2.60     $ 2.80  
 Consolidated Health Benefits Ratio
    87.0 %     88.0 %
 General & Administrative expense ratio
    9.5 %     10.0 %
                 
    Diluted Shares Outstanding (in thousands)     53,400   

The above guidance has not been adjusted to include the impact associated with the Washington RFP and assumes that the Texas expansion will begin on March 1 with required CMS approval of premium rates.

Conference Call

As previously announced, the Company will host a conference call Tuesday, February 7, 2012, at 8:30 A.M. (Eastern Time) to review the financial results for the fourth quarter and year ended December 31, 2011, and to discuss its business outlook.  Michael F. Neidorff and William N. Scheffel will host the conference call.  Investors and other interested parties are invited to listen to the conference call by dialing 1-800-860-2442 in the U.S. and Canada; +1-412-858-4600 from abroad; or via a live, audio webcast on the Company’s website at www.centene.com, under the Investors section.  A webcast replay will be available for on-demand listening shortly after the completion of the call for the next twelve months or until 11:59 PM (Eastern Time) on Tuesday, February 12, 2013, at the aforementioned URL. In addition, a digital audio playback will be available until 9:00 AM Eastern Time on Wednesday, February 15, 2012, by dialing 1-877-344-7529 in the U.S. and Canada, or +1-412-317-0088  from abroad, and entering access code 10008192.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and long-term care, in addition to other state-sponsored/hybrid programs, and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique, "exchange based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management.
 
The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene. Subsequent events and developments may cause the Company's estimates to change. The Company disclaims any obligation to update this forward-looking financial information in the future. Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses, competition, membership and revenue projections, timing of regulatory contract approval, changes in healthcare practices, changes in federal or state laws or regulations, inflation, provider contract changes, new technologies, reduction in provider payments by governmental payors, major epidemics, disasters and numerous other factors affecting the delivery and cost of healthcare. The expiration, cancellation or suspension of Centene's Medicaid Managed Care contracts by state governments would also negatively affect Centene.

 
 [Tables Follow]
 
 
 

 
Centene Corporation Reports 2011 Fourth Quarter and Full Year Results February 7, 2012/Page 4
 
CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)

 
     December 31,  
   
2011
   
2010
 
 ASSETS
           
 Current assets:
           
Cash and cash equivalents
  $ 573,698     $ 434,166  
Premium and related receivables, net of allowance for uncollectible accounts of $639 and $17, respectively
    157,450       136,243  
Short-term investments, at fair value (amortized cost $129,232 and $21,141, respectively)
    130,499       21,346  
Other current assets
    78,363       65,066  
Total current assets
    940,010       656,821  
 Long-term investments, at fair value (amortized cost $497,805 and $585,862, respectively)
    506,140       595,879  
 Restricted deposits, at fair value (amortized cost $26,751 and $22,755, respectively)
    26,818       22,758  
 Property, software and equipment, net of accumulated depreciation of $177,294 and $138,629, respectively
    349,622       326,341  
 Goodwill
    281,981       278,051  
 Intangible assets, net
    27,430       29,109  
 Other long-term assets
    58,335       34,923  
Total assets
  $ 2,190,336     $ 1,943,882  
 
 LIABILITIES AND STOCKHOLDERS’ EQUITY
               
 Current liabilities:
               
Medical claims liability
  $ 607,985     $ 456,765  
Accounts payable and accrued expenses
    216,504       188,320  
Unearned revenue
    9,890       117,344  
Current portion of long-term debt
    3,234       2,817  
Total current liabilities
    837,613       765,246  
 Long-term debt
    348,344       327,824  
 Other long-term liabilities
    67,960       53,757  
Total liabilities
    1,253,917       1,146,827  
                 
 Commitments and contingencies
               
                 
 Stockholders’ equity:
               
Common stock, $.001 par value; authorized 100,000,000 shares; 53,586,726 issued and 50,864,618 outstanding at December 31, 2011, and 52,172,037 issued and 49,616,824 outstanding at December 31, 2010
    54       52  
Additional paid-in capital
    421,981       384,206  
Accumulated other comprehensive income:
               
Unrealized gain on investments, net of tax
    5,761       6,424  
Retained earnings
    564,961       453,743  
Treasury stock, at cost (2,722,108 and 2,555,213 shares, respectively)
    (57,123 )     (50,486 )
Total Centene stockholders’ equity
    935,634       793,939  
Noncontrolling interest
    785       3,116  
Total stockholders’ equity
    936,419       797,055  
Total liabilities and stockholders’ equity
  $ 2,190,336     $ 1,943,882  
 
 
 

 
Centene Corporation Reports 2011 Fourth Quarter and Full Year Results February 7, 2012/Page 5

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share data)
(Unaudited)

 
Three Months Ended December 31,
 
Year Ended December 31,
 
 
2011
 
2010
 
2011
 
2010
 
 Revenues:
                       
Premium
$
1,436,413
 
$
1,106,370
 
$
5,077,242
 
$
4,192,172
 
Service
 
22,136
   
23,118
   
103,765
   
91,661
 
Premium and service revenues
 
1,458,549
   
1,129,488
   
5,181,007
   
4,283,833
 
Premium tax
 
48,627
   
51,481
   
159,575
   
164,490
 
Total revenues
 
1,507,176
   
1,180,969
   
5,340,582
   
4,448,323
 
 Expenses:
                       
Medical costs
 
1,233,739
   
940,935
   
4,324,746
   
3,584,452
 
Cost of services
 
17,397
   
16,414
   
78,114
   
63,919
 
General and administrative expenses
 
159,937
   
127,886
   
587,004
   
477,765
 
Premium tax
 
48,726
   
50,233
   
160,394
   
165,118
 
Total operating expenses
 
1,459,799
   
1,135,468
   
5,150,258
   
4,291,254
 
Earnings from operations
 
47,377
   
45,501
   
190,324
   
157,069
 
 Other income (expense):
                       
Investment and other income
 
3,990
   
3,293
   
13,369
   
15,205
 
Debt extinguishment costs
 
   
   
(8,488
)
 
 
Interest expense
 
(4,797
)
 
(5,452
)
 
(20,320
)
 
(17,992
)
Earnings from continuing operations, before income tax expense
 
46,570
   
43,342
   
174,885
   
154,282
 
Income tax expense
 
17,306
   
16,958
   
66,522
   
59,900
 
Earnings from continuing operations, net of income tax expense
 
29,264
   
26,384
   
108,363
   
94,382
 
 Discontinued operations, net of income tax expense of $0, $12, $0 and $4,388, respectively
 
   
(65
)
 
   
3,889
 
Net earnings
 
29,264
   
26,319
   
108,363
   
98,271
 
 Noncontrolling interest
 
(848
)
 
920
   
(2,855
)
 
3,435
 
Net earnings attributable to Centene Corporation
$
30,112
 
$
25,399
 
$
111,218
 
$
94,836
 
                         
 Amounts attributable to Centene Corporation common shareholders:
                       
Earnings from continuing operations, net of income tax expense
$
30,112
 
$
25,464
 
$
111,218
 
$
90,947
 
Discontinued operations, net of income tax (benefit) expense
 
   
(65
)
 
   
3,889
 
Net earnings
$
30,112
 
$
25,399
 
$
111,218
 
$
94,836
 
                         
 Net earnings per share attributable to Centene Corporation:
                       
Basic:
                       
Continuing operations
$
0.60
 
$
0.52
 
$
2.22
 
$
1.87
 
Discontinued operations
 
   
   
   
0.08
 
Earnings per common share
$
0.60
 
$
0.52
 
$
2.22
 
$
1.95
 
Diluted:
                       
Continuing operations
$
0.57
 
$
0.50
 
$
2.12
 
$
1.80
 
Discontinued operations
 
   
   
   
0.08
 
Earnings per common share
$
0.57
 
$
0.50
 
$
2.12
 
$
1.88
 
                         
 Weighted average number of shares outstanding:
                       
Basic
 
50,522,726
   
49,356,768
   
50,198,954
   
48,754,947
 
Diluted
 
52,894,701
   
51,205,720
   
52,474,238
   
50,447,888
 

 
 

 
Centene Corporation Reports 2011 Fourth Quarter and Full Year Results February 7, 2012/Page 6
 
CENTENE CORPORATION AND SUBSIDIARIES
 
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
 
   
Year Ended December 31,
 
   
2011
   
2010
 
 Cash flows from operating activities:
               
Net earnings
 
$
108,363
   
$
98,271
 
Adjustments to reconcile net earnings to net cash provided by operating activities:
               
Depreciation and amortization
   
58,327
     
52,000
 
Stock compensation expense
   
18,171
     
13,874
 
Gain on sale of investments, net
   
(287
)
   
(6,337
)
Debt extinguishment costs
   
8,488
     
— 
 
(Gain) on sale of UHP
   
     
(8,201
)
Impairment loss on Casenet, LLC
   
     
5,531
 
Deferred income taxes
   
2,031
     
10,317
 
Changes in assets and liabilities:
               
Premium and related receivables
   
(11,306
   
(23,359
)
Other current assets
   
(11,812
)
   
(3,240
)
Other assets
   
(2
   
(2,028
)
Medical claims liability
   
149,756
     
(30,421
)
Unearned revenue
   
(109,082
   
25,700
 
Accounts payable and accrued expenses
   
38,889
     
37,398
 
Other operating activities
   
10,160
     
(573
)
Net cash provided by operating activities
   
261,696
     
168,932
 
 Cash flows from investing activities:
               
Capital expenditures
   
(68,993
)
   
(63,304
)
Capital expenditures of Centene Center LLC
   
(4,715
)
   
(55,252
)
Purchase of investments
   
(318,397
)
   
(615,506
)
Sales and maturities of investments
   
267,404
     
570,423
 
Proceeds from asset sales
   
     
13,420
 
Investments in acquisitions, net of cash acquired, and investment in equity method investee
   
(4,375
)
   
(60,388
)
Net cash used in investing activities
   
(129,076
)
   
(210,607
)
 Cash flows from financing activities:
               
Proceeds from exercise of stock options
   
15,815
     
3,419
 
Proceeds from borrowings
   
419,183
     
218,538
 
Proceeds from stock offering
   
     
104,534
 
Payment of long-term debt
   
(416,283
)
   
(195,728
)
Purchase of noncontrolling interest
   
     
(48,257
)
Distributions from (to) noncontrolling interest
   
813
     
(7,387
)
Excess tax benefits from stock compensation
   
4,435
     
963
 
Common stock repurchases
   
(7,809
)
   
(3,224
)
Debt issue costs
   
(9,242
)
   
(769
)
Net cash provided by financing activities
   
6,912
     
72,089
 
Net increase in cash and cash equivalents
   
139,532
     
30,414
 
 Cash and cash equivalents, beginning of period
   
434,166
     
403,752
 
 Cash and cash equivalents, end of period
 
$
573,698
   
$
434,166
 
                 
 Supplemental disclosures of cash flow information:
               
Interest paid
 
$
27,383
   
$
17,296
 
Income taxes paid
 
$
50,444
   
$
53,938
 
                 
 Supplemental disclosure of non-cash investing and financing activities:
               
Contribution from noncontrolling interest
 
$
   
$
306
 
Capital expenditures
 
$
6,591
   
$
8,720
 

 
 

 
Centene Corporation Reports 2011 Fourth Quarter and Full Year Results February 7, 2012/Page 7

CENTENE CORPORATION

CONTINUING OPERATIONS SUPPLEMENTAL FINANCIAL DATA

      Q4     Q3     Q2     Q1     Q4  
      2011     2011     2011     2011     2010  
 MEMBERSHIP
                               
 Managed Care:
                               
Arizona                                              
    23,700     22,800     22,800     22,600     22,400  
Florida                                              
    198,300     188,600     190,600     188,800     194,900  
Georgia                                              
    298,200     298,000     303,100     303,300     305,800  
Illinois                                              
    16,300     13,600     700          
Indiana                                              
    206,900     205,300     206,700     209,400     215,800  
Kentucky                                      
    180,700                  
Massachusetts                                              
    35,700     34,700     32,900     34,100     36,200  
Mississippi                                              
    31,600     30,600     30,800          
Ohio                                              
    159,900     162,200     159,900     160,900     160,100  
South Carolina                                              
    82,900     86,500     82,800     84,900     90,300  
Texas                                              
    503,800     494,500     470,400     456,700     433,100  
Wisconsin                                              
    78,000     78,900     79,800     81,800     74,900  
Total at-risk membership
    1,816,000     1,615,700     1,580,500     1,542,500     1,533,500  
Non-risk membership                                              
    4,900     10,600     10,400     10,400     4,200  
TOTAL                                      
    1,820,900     1,626,300     1,590,900     1,552,900     1,537,700  
                                 
                                 
Medicaid                                              
    1,336,800     1,189,900     1,172,400     1,169,700     1,177,100  
CHIP & Foster Care                                              
    213,900     210,600     211,400     208,900     210,500  
ABD & Medicare                                              
    218,000     171,700     156,300     123,800     104,600  
Hybrid Programs                                              
    40,500     38,400     35,500     35,200     36,200  
Long-term Care                                              
    6,800     5,100     4,900     4,900     5,100  
Total at-risk membership
    1,816,000     1,615,700     1,580,500     1,542,500     1,533,500  
Non-risk membership                                              
    4,900     10,600     10,400     10,400     4,200  
TOTAL                                      
    1,820,900     1,626,300     1,590,900     1,552,900     1,537,700  
                                 
 Specialty Services(a):
                               
Cenpatico Behavioral Health
                               
Arizona                                              
    168,900     175,500     173,200     172,700     174,600  
Kansas                                              
    46,200     45,600     45,000     44,000     39,200  
TOTAL                                      
    215,100     221,100     218,200     216,700     213,800  
                                 
 (a) Includes external membership only.
                         
                                 
 REVENUE PER MEMBER PER MONTH(b)
  $ 261.95   $ 245.27   $ 240.57   $ 238.31   $ 239.66  
                                 
 CLAIMS(b)
                               
Period-end inventory                                              
    495,500     482,900     415,700     527,100     434,900  
Average inventory                                              
    367,590     312,400     332,300     347,900     304,700  
Period-end inventory per member
    0.27     0.30     0.26     0.34     0.28  
 (b) Revenue per member and claims information are presented for the Managed Care at-risk members.
 
                                 
 NUMBER OF EMPLOYEES     5,300      5,000      4,800      4,500      4,200  

 
 

 
Centene Corporation Reports 2011 Fourth Quarter and Full Year Results February 7, 2012/Page 8

 
Q4
 
Q3
 
Q2
 
Q1
 
Q4
 
2011
 
2011
 
2011
 
2011
 
2010
                   
 DAYS IN CLAIMS PAYABLE (c)
45.3
 
43.6
 
43.4
 
43.4
 
44.7
 (c) Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.
 
 CASH AND INVESTMENTS (in millions)
               
Regulated                                              
$
1,198.9
 
$
1,079.3
 
$
1,061.9
 
$
1,096.3
 
$
1,043.0
Unregulated                                              
 
38.2
   
35.9
   
36.5
   
31.7
   
30.9
TOTAL                                      
$
1,237.1
 
$
1,115.2
 
$
1,098.4
 
$
1,128.0
 
$
1,073.9
                   
 DEBT TO CAPITALIZATION
27.3%
 
28.0%
 
28.1%
 
26.9%
 
29.3%
 DEBT TO CAPITALIZATION EXCLUDING NON-RECOURSE DEBT(d)
22.6%
 
23.2%
 
23.0%
 
21.4%
 
23.9%
 Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity).
 (d) The non-recourse debt represents our mortgage note payable ($77.8 million at December 31, 2011).

MEDICAL COST / GENERAL AND ADMINISRATIVE EXPENSE RECLASSIFICATION IMPACT ($ in thousands):

   
Three Months Ended December 31,
   
Year Ended December 31,
 
   
2011
   
2010
   
2011
   
2010
 
   
Medical Costs
   
HBR
   
Medical Costs
   
HBR
   
Medical Costs
   
HBR
   
Medical Costs
   
HBR
 
 Historical
  $ 1,206,516       84.0 %   $ 922,070       83.3 %   $ 4,227,916       83.3 %   $ 3,514,394       83.8 %
 Reclassification impact
    27,223       1.9       18,865       1.7       96,830       1.9       70,058       1.7  
 Revised
  $ 1,233,739       85.9 %   $ 940,935       85.0 %   $ 4,324,746       85.2 %   $ 3,584,452       85.5 %

   
Three Months Ended December 31,
   
Year Ended December 31,
 
   
2011
   
2010
   
2011
   
2010
 
   
G&A Expense
   
G&A Ratio
   
G&A Expense
   
G&A Ratio
   
G&A Expense
   
G&A Ratio
   
G&A Expense
   
G&A Ratio
 
 Historical
  $ 187,160       12.8 %   $ 146,751       13.0 %   $ 683,834       13.2 %   $ 547,823       12.8 %
 Reclassification impact
    (27,223 )     (1.8 )       (18,865 )     (1.7 )       (96,830 )     (1.9 )       (70,058 )     (1.6 )  
 Revised
  $ 159,937       11.0 %   $ 127,886       11.3 %   $ 587,004       11.3 %   $ 477,765       11.2 %
 
OPERATING RATIOS:
 
Three Months Ended December 31,
 
Year Ended December 31,
 
2011
 
2010
 
2011
 
2010
 Health Benefits Ratios:
                     
   Medicaid and CHIP
82.9
%
 
83.7
%
 
82.4
%
 
85.0
%
   ABD and Medicare
88.8
   
89.1
   
89.8
   
87.1
 
   Specialty Services
94.0
   
86.1
   
89.1
   
86.2
 
   Total
85.9
   
85.0
   
85.2
   
85.5
 
                       
 Total General & Administrative Expense Ratio
11.0
%
 
11.3
%
 
11.3
%
 
11.2
%
 
MEDICAL CLAIMS LIABILITY (In thousands)
 
The changes in medical claims liability are summarized as follows:

 Balance, December 31, 2010
  $ 456,765  
 Incurred related to:
       
Current period
    4,390,123  
Prior period
    (65,377 )
Total incurred
    4,324,746  
 Paid related to:
       
Current period
    3,788,808  
Prior period
    384,718  
Total paid
    4,173,526  
 Balance, December 31, 2011
  $ 607,985  
 
Centene’s claims reserving process utilizes a consistent actuarial methodology to estimate Centene’s ultimate liability.  Any reduction in the “Incurred related to:  Prior period” amount may be offset as Centene actuarially determines “Incurred related to: Current period.”  As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs.  Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.

The amount of the “Incurred related to: Prior period” above represents favorable development and includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service prior to December 31, 2010.